Article
Next-generation sequencing demonstrates the rarity of short kinase variants specific to quadruple wild-type gastrointestinal stromal tumours.
Journal of clinical pathology - 1 Mar 2021
Wong Newton A C S, Giger Olivier T, Ten Hoopen Rogier, Casey Ruth T, Russell Kirsty, Faulkner Claire
Abstract excerpt
AIM: There is no known specific biomarker or genetic signal for quadruple wild-type (qWT) gastrointestinal stromal tumours (GISTs). By next-generation sequencing (NGS) of different GIST subgroups, this study aimed to characterise such a biomarker especially as a potential therapeutic target. METHODS AND RESULTS: An NGS panel of 672 kinase genes was applied to DNA extracted from 11 wild-type GISTs (including three...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
